Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 5.10 BATS BZX Real-Time Price As of Sep 21 |  0.00 / 0.00%Today’s Change | 5.00 Today|||52-Week Range 43.20 | -70.07% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 1.0M | 1.6M | 4.0M | 4.8M | |
| Short Term Investment Cash | 460.9K | 618.4K | 2.1M | 1.1M | ||
| Cash & Short Term Investments | 3.0M | 8.0M | 8.0M | 4.8M | ||
| Receivables | Receivables | 48.1K | 172.0K | 70.6K | 57.8K | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 57.8K | 207.6K | 165.1K | 160.6K | |
| Current Assets | 3.1M | 8.4M | 8.2M | 5.0M | ||
| Total Assets | Property, Plant and Equipment - Gross | 332.0K | 456.5K | 604.9K | 736.5K | |
| Depreciation | -27.0K | -99.8K | -217.8K | -323.3K | ||
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Total Assets | 3.4M | 8.8M | 8.7M | 5.5M | ||
| Liabilities | Accounts Payable | 119.8K | 349.0K | 490.5K | 237.4K | |
| Short Term Debt | 0.00 | 15.1K | 0.00 | 0.00 | ||
| Accrued Expenses | 253.1K | 102.1K | 123.9K | 401.2K | ||
| Other Current Liabilities | 444.9K | 105.8K | 127.3K | 453.6K | ||
| Other Liabilities | 735.0K | 905.5K | 1.2M | 1.3M | ||
| Total Liabilities | Other Liabilities | 0.00 | 503.6K | 2.1M | 486.0K | |
| Total Liabilities | 735.0K | 1.4M | 3.3M | 1.8M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 2.7M | 7.4M | 5.4M | 3.7M | ||
| Total Shareholder Equity | 2.7M | 7.4M | 5.4M | 3.7M | ||
| Share Information | Common Shares Outstanding | 3.8M | 5.4M | 6.0M | 6.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
